Growth in the neuromuscular disease market is fueled by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), and next-generation small-molecule and monoclonal antibody treatments. https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html